DGAP-News

MeVis Medical Solutions AG: MeVis Q3 2015: Previous trend continued

DGAP-News: MeVis Medical Solutions AG / Key word(s): 9-month
figures/Interim Report
MeVis Medical Solutions AG: MeVis Q3 2015: Previous trend continued

19.11.2015 / 09:30

---------------------------------------------------------------------

Significant increase in revenues from strong US dollar

- Sales in the third quarter increased by 33 % to EUR 4.8 m primarily due
to the strong US dollar (prev. year: EUR 3.6 m)

- Earnings before interest and taxes (EBIT) increased to EUR 3.6 m after
nine month (prev. year EUR 3.2 m), EBIT margin of 30 %

- Net profit declined cumulatively by EUR 0.5 m to EUR 3.0 m

- Liquidity of EUR 22.0 m as at September 30, 2015 (Dec. 31, 2014: EUR
17.5 m)

- Domination and profit and loss transfer agreement legally effective

Bremen, November 19, 2015 - MeVis Medical Solutions AG [ISIN:
DE000A0LBFE4], a leading provider of medical imaging software, today
announced its results for the first three quarters of 2015.

Sales generated in the third quarter of 2015 amounted to EUR 4,795 k, a
significant 33 % higher than in the corresponding quarter of 2014 (EUR
3,599 k). Thus, in the first nine month sales increased considerably year
on year to EUR 11,933 (prev. year: EUR 9,661 k). The growth in sales of EUR
2,272 is largely attributable to the changes of the US dollar, which
contributed EUR 1,781 k to sales growth. Software development services
totaling EUR 522 k (prev. year: EUR 0 k) following the agreement concluded
with Hologic in September 2014 are also included in sales for the first
nine months of 2015. Including the positive effect of the strong US dollar,
sales in the new license business improved by 16 % to EUR 5,901 k, while
sales in the maintenance business grew by 19 % to EUR 5,093 k, accounting
for 43 % of total sales. Sales in the Digital Mammography segment were up
by 30 % to EUR 9,454 k (prev. year: EUR 7,280 k), while sales in the Other
Diagnostics segment grew slightly by 4 % to EUR 2,479 k (prev. year: EUR
2,381 k).

Staff costs increased in the third quarter according to plan by 5 % to EUR
1,735 k (prev. year: EUR 1,641 k), resulting in an cumulative increase of 3
% (from EUR 5,370 k to EUR 5,208 k) for the first nine month. Primarily due
to increased consulting costs in connection with the domination and profit
and loss transfer agreement, other operating expenses rose in the third
quarter in a year on year comparison to EUR 916 k (prev. year: EUR 572 k),
and, cumulated for the first nine months of 2015, increased by 24 %.